Novo Nordisk Articles
Novo Nordisk sees 4% profits rise for 2004
14 February 2005
Savient in partial deal with Novo Nordisk on hGH patent
7 February 2005
Novo Nordisk US appointments
7 February 2005
Novo Nordisk's Norditropin NordiFlex debuts in USA
31 January 2005
ADA and Novo Nordisk announce grant recipients
31 January 2005
MIP Tech and Novo Nordisk's FeF Chem in deal
31 January 2005
New product launches in 2004
31 January 2005
Poor year for MNCs in Poland
31 January 2005
Personnel changes at Novo Nordisk
10 January 2005
Novo Nordisk recruits two ex-Aventis execs for US posts
10 January 2005
Novo Nordisk updates on NovoSeven label expansion
10 January 2005
$12.5M placing by Aradigm
10 January 2005
Pharma plant built in new record time of 14.5 months
20 December 2004
New use for Novo Nordisk's Norditropin
15 November 2004
Novo Nordisk plans $100M US insulin plant
8 November 2004
Novo Nordisk's 3rd-qtr net profit rises 11%
8 November 2004
Novo Nordisk halts DRF 2593 development
1 November 2004
Novo Nordisk gains recombinant Factor XIII
11 October 2004
Novo expands rights to Aradigm's AERx iDMS
4 October 2004
Sumitomo to develop repaglinide in Japan
27 September 2004
Promising new data for Novo Nordisk's liraglutide
20 September 2004
Serono enters research and license deal with Zymogenetics which could exceed $100M
20 September 2004
Novo Nordisk promoted Michael Shalmi
13 September 2004
Novo Nordisk to appeal court's hGH patent rulings
13 September 2004
Novo Nordisk completes $6M investment in Transition Therapeutics
6 September 2004
Novo Nordisk reports trading by "insiders"
23 August 2004
Novo Nordisk posts unexpected rise in 2nd-qtr profit
23 August 2004
Teva and Savient get favorable ruling on rHGH
16 August 2004
Innate raises 15M euros in intermediate financing
9 August 2004
ZymoGenetics licenses drugs to Novo Nordisk
12 July 2004
Novo Nordisk to buy Indar?
12 July 2004
Promotions at Novo Nordisk
5 July 2004
Novo Nordisk's Levemir available in UK
28 June 2004
Novo Nordisk extends option with ZymoGenetics
14 June 2004
EU clears Novo Nordisk's Levemir
14 June 2004
Novo ups 2004 forecast on strong 1st-qtr
10 May 2004
Hungarian govt goes ahead with 15% drug price reductions
19 April 2004
Novo Nordisk breaks ground on new facility
12 April 2004
Confusion in EU biogenerics sector
5 April 2004
Novo Nordisk enrolls Innovex for menopause drugs sales
29 March 2004
ZymoGenetics and Novo Nordisk sign deal
22 March 2004
Serologicals expands distribution deal with Novo Nordisk
15 March 2004
Novo Nordisk's Levemir on track in EU
8 March 2004
NovoSeven cleared in EU for two new uses
1 March 2004
Novo Nordisk names chief govt affairs officer in USA
23 February 2004
Novo Nordisk profits up 19% in 2003
16 February 2004
Novo Nordisk expands French insulin production capacity
2 February 2004
Novo Nordisk signs accord with Innate
15 December 2003
Neose and Novo Nordisk enter collab
24 November 2003
Novo Nordisk and the NHF to launch hemophilia web site
24 November 2003
Transition and Novo Nordisk sign deal
17 November 2003
Approvable letter for Levemir from FDA
20 October 2003
Novo Nordisk updates shareholdings
13 October 2003
Novo Nordisk invests 130 million euros in insulin cartridge facility
22 September 2003
Novo Nordisk
8 September 2003
Novo Nordisk
18 August 2003
Novo Nordisk completes initial stake in Transition
4 August 2003
Novo Nordisk's Norditropin cleared by EC
7 July 2003
Pfizer tries to end Novo HRT deal
9 June 2003
Promotions at Novo Nordisk in USA
12 May 2003
Profits up at Novo Nordisk in first qtr
12 May 2003
Novo Nordisk continues Clayton, USA, expansion
12 May 2003
NovoNordisk promotes Michael Dwyer in the USA
28 April 2003
Fournier to co-market repaglinide in Europe
28 April 2003
Novo A/S invests in US biotech firm Corus
14 April 2003
New use for Norditropin backed in EU
31 March 2003
NovoLog FlexPen launched in USA
10 March 2003
Novo Nordisk
17 February 2003
Paladin's earnings up for full-year 2002
17 February 2003
Round-up of pharmaceutical mergers and acquisitions during 2001
13 January 2003
Novo Nordisk updates on share repurchasing
13 January 2003
Tom Mmartin moves to US post at Novo Nordisk
6 January 2003
Novozymes' figures are up for first half of 2002
19 August 2002
Novo Nordisk names US director of strategic sourcing
12 August 2002
Novo Nordisk 1st half allays fears
12 August 2002
Novo Nordisk stops ragaglitazar trials
29 July 2002
Novo Nordisk promotes Patrick Loustau
1 July 2002
Exubera superior to oral drugs in diabetes
24 June 2002
Dr Reddy's completes Phase I trial of DRF-1042
20 May 2002
Novo Nordisk net profit plunges 21%
13 May 2002
Appointments at Novo Nordisk Pharmaceuticals
22 April 2002
Profit warning at Novo Nordisk
22 April 2002
Appointments at Novo Nordisk
1 April 2002
Novo launches new insulin product in EU
1 April 2002
Novo Nordisk views EU hostile takeover report
18 March 2002
Losses narrow at France's Flamel
18 March 2002
Zymogenetics sues Immunex over Enbrel
18 March 2002
Pretax profits up 25% at Novo Nordisk
18 February 2002
Novo Nordisk terminates Basulin agreement with Flamel.
21 January 2002
ZymoGenetics files IPO in the USA.
21 January 2002
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
